Identification of Specific Binding Sites for Glucagon-Like Peptide-1 on the Posterior Lobe of the Rat Pituitary
The DOI matches its Crossref record.
Abstract
Glucagon-like peptide-1 (GLP-1) immunoreactivity has been found in autonomic and neuroendocrine brain regions, whereas only limited data are available regarding the characterization and localization of brain GLP-1 receptors. In the present study, using quantitative in vitro autoradiography, a high density of specific binding sites for GLP-1 was characterized on sections of the posterior pituitary lobe of the rat. Low specific binding of radiolabeled GLP-1 was found in the anterior lobe and no specific binding in the intermediate lobe. To examine the specificity of GLP-1 binding sites, sections of the posterior lobe were incubated with radiolabeled GLP-1 in the presence of various peptides. Radiolabeled [Tyr39]exendin-4, a specific GLP-1 agonist, bound to these receptor sites with the same affinity as GLP-1, while glucagon and vasoactive intestinal peptide (VIP) were unable to displace 125I-GLP-1. Both unlabeled exendin-4 and GLP-1 inhibited this binding with equally high affinity. Using 125I-[Tyr39]exendin-4 as radiolabel, the concentration of binding sites was found to be 7.8 ± 0.4 fmol/mg tissue. Further analysis of the binding data from experiments with tissue slices revealed the presence of high and low affinity binding sites. In experiments with unlabeled [Tyr39]exendin-4, the Kds were 6.2 ± 1.4 × 10–12 and 9.3 ± 1.5 × 10–10M, respectively, and in experiments with unlabeled GLP-1, 3.4 ± 1.8 × 10-12 and 5.9 ± 1.5 × 10-10M, respectively. Since both GLP-1 and [Tyr39]exendin-4 reveal the same binding characteristics, it is concluded that both peptides bind to the same receptor sites in the rat posterior pituitary lobe. 125I-GLP-1 and 125I-[Tyr39]exendin-4 also specifically bound to the nucleus of the solitary tract, the subfornical organ, the median eminence, the lateral mammillary nucleus and the lateral subnucleus of the interpeduncular nucleus. The presence of GLP-1-binding sites in different circumventricular organs suggests that this hormone may serve to modulate autonomic and neuroendocrine functions in the rat brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Kieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
The role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824
“In addition, GLP-1R is present in the nodose ganglion neurons of the vagus nerve and several regions of CNS, including the NTS of brainstem and hypothalamus (Göke et al., 1995a; Larsen et al., 1997; Nakagawa et al., 2004).”
BackgroundLarsen, P. J., Tang-Christensen, M., Holst, J. J., & Ørskov, C. (1997) · Neuroscience · doi:10.1016/s0306-4522(96)00434-4 · Cited by 663
Larsen, P. J. (1997) · Endocrinology · doi:10.1210/en.138.10.4445 · Cited by 316
Self-citationKnauf, C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25764 · Cited by 308
Metadata
- Authors
- Göke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P.
- Venue
- Neuroendocrinology
- Publisher
- S. Karger AG
- Published
- 1995
- Volume
- 62
- Issue
- 2
- Pages
- 130-134
- ISSN
- 0028-3835 (ISSN-L)
- 1423-0194
- OpenAlex
- W1965307991
- Cited by
- 57
- References
- 0
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification of Specific Binding Sites for Glucagon-Like Peptide-1 on the Posterior Lobe of the Rat Pituitary. https://app.cochat.ai/papers/10.1159/000126997
- The paper
- Göke, R., Larsen, P. J., Mikkelsen, J. D., & Sheikh, S. P. (1995). Identification of Specific Binding Sites for Glucagon-Like Peptide-1 on the Posterior Lobe of the Rat Pituitary. Neuroendocrinology. https://doi.org/10.1159/000126997
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.